CAS 55400-73-2: 13,13-dioxido-3,6,9,12-tetraoxa-13-thiatetradec-1-yl methanesulfonate (non-preferred name)
Formula:C10H22O9S2
InChI:InChI=1/C10H22O9S2/c1-20(11,12)18-9-7-16-5-3-15-4-6-17-8-10-19-21(2,13)14/h3-10H2,1-2H3
SMILES:CS(=O)(=O)OCCOCCOCCOCCOS(=O)(=O)C
Sort by
Found 4 products.
1,11-Bis(methanesulfonyloxy)-3,6,9-trioxandecane
CAS:Controlled ProductApplications 1,11-Bis(methanesulfonyloxy)-3,6,9-trioxandecane (cas# 55400-73-2) is a compound useful in organic synthesis. References Chan, K., et al.: J. Med. Chem., 49, 6742 (2006),Formula:C10H22O9S2Color and Shape:NeatMolecular weight:350.411,11-BIS(METHANESULFONYLOXY)-3,6,9-TRIOXANDECANE
CAS:Formula:C10H22O9S2Purity:95%Color and Shape:LiquidMolecular weight:350.40628000000004Ms-PEG4-Ms
CAS:Ms-PEG4-Ms is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules.Formula:C10H22O9S2Purity:98%Color and Shape:SolidMolecular weight:350.411,11-Bis(methanesulfonyloxy)-3,6,9-trioxandecane
CAS:1,11-Bis(methanesulfonyloxy)-3,6,9-trioxandecane is a macrocyclic compound that is used as a cancer chemotherapy drug. It binds to the transporter and inhibits the efflux of drugs from cells into the bloodstream. This interaction with multidrug transporters is thought to be responsible for its anti-cancer effects. 1,11-Bis(methanesulfonyloxy)-3,6,9-trioxandecane has been shown to selectively interact with electron transfer proteins such as cytochrome P450 reductase and cytochrome P450 reductase 2C8 (CYP2C8). It also interacts with macrocycles such as those in DNA gyrase and topoisomerases.Formula:C10H22O9S2Purity:Min. 95%Molecular weight:350.41 g/molRef: 3D-FB18736
Discontinued product
